IFM Investors Pty Ltd boosted its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 5.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 124,065 shares of the company’s stock after acquiring an additional 6,238 shares during the quarter. IFM Investors Pty Ltd’s holdings in Avantor were worth $1,670,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of AVTR. Rise Advisors LLC purchased a new stake in shares of Avantor during the 1st quarter worth about $25,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Avantor by 288.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock worth $28,000 after purchasing an additional 1,263 shares in the last quarter. Wealthquest Corp purchased a new stake in shares of Avantor during the 1st quarter worth about $34,000. GAMMA Investing LLC raised its stake in shares of Avantor by 121.6% during the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock worth $61,000 after purchasing an additional 2,056 shares in the last quarter. Finally, Fifth Third Bancorp raised its stake in shares of Avantor by 52.0% during the 1st quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock worth $64,000 after purchasing an additional 1,359 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on AVTR shares. Raymond James Financial set a $14.00 price target on Avantor and gave the stock an “outperform” rating in a research note on Monday, August 4th. Barclays reissued an “overweight” rating and issued a $13.00 price objective (down from $15.00) on shares of Avantor in a research note on Monday, August 4th. Royal Bank Of Canada cut their price objective on Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Jefferies Financial Group reissued a “hold” rating on shares of Avantor in a research note on Friday, August 1st. Finally, Wells Fargo & Company cut their price objective on Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $15.50.
Insider Buying and Selling at Avantor
In other news, CAO Steven W. Eck sold 3,476 shares of the business’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer owned 55,068 shares in the company, valued at $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.20% of the stock is currently owned by insiders.
Avantor Trading Down 0.3%
Shares of AVTR opened at $12.46 on Tuesday. The stock has a fifty day moving average price of $12.87 and a two-hundred day moving average price of $13.73. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98. Avantor, Inc. has a 52-week low of $10.82 and a 52-week high of $27.09. The company has a market cap of $8.50 billion, a price-to-earnings ratio of 12.59, a PEG ratio of 1.42 and a beta of 0.98.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the firm posted $0.25 EPS. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. Analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What is MarketRank� How to Use it
- How The Weak Dollar Is Fueling These Global Stock Surges
- How to find penny stocks to invest and tradeĀ
- 3 Recession-Ready Stocks That Thrive When the Economy Sputters
- Investing in Travel Stocks Benefits
- 3 Automation-Focused Stocks Flying Under the Radar
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.